Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone
Clinical trial NCT06388616 · COMPLETED
Trial details
- NCT number
- NCT06388616
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2024-09-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.